Earnings Ahead

LGND - Ligand Pharmaceuticals Inc.

71.7 -0.56 -0.78

Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

LGND



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Ligand Pharmaceuticals Non-GAAP EPS of $1.05 beats by $0.39, revenue of $28.1M beats by $2.46M
  • Ligand Pharmaceuticals Q4 2023 Earnings Preview
  • Esai gets Japanese approval for epilepsy drug using Ligand technology
  • Small cap value stocks with potential M&A candidacy - BofA
  • Johnson & Johnson posts Q4 beat as pharma and MedTech outperform
  • FDA approves Ligand's Zelsuvmi for treatment of molluscum
  • Ligand Pharmaceuticals Non-GAAP EPS of $1.02 beats by $0.40, revenue of $32.87M beats by $5.65M
  • Ligand Pharmaceuticals Q3 2023 Earnings Preview
  • Ligand acquires royalty on Sanofi’s TZIELD for $20 million
  • Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
  • Morgan Stanley: 81 companies will have technical pressures due to tax loss selling
  • Ligand Pharmaceuticals closes acquisition of assets of Novan
  • Ligand Pharmaceuticals' CEO Davis Todd increases shareholding
  • Ligand spins out Pelican unit as separate company, updates guidance
  • Ligand Pharmaceuticals Non-GAAP EPS of $1.42 beats by $0.76, revenue of $26.4M beats by $0.67M
  • Ligand Pharmaceuticals Q2 2023 Earnings Preview
  • Novan craters as company files for bankruptcy, to sell most of its assets
  • Ligand Pharma up 5% after hours on 2023 guidance boosts
  • Ligand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39, revenue of $43.9M beats by $10.35M
  • Ligand Pharmaceuticals Q1 2023 Earnings Preview
Date Price Open High Low Vol Change ER
Mar 4 96.92 99.51
101.10
96.40
188.00K -4%
Mar 3 100.96 103.10
103.72
99.51
143.69K -1.37%
Mar 2 102.36 97.83
104.18
97.37
134.96K 4.66%
Mar 1 97.80 100.46
102.27
96.79
242.33K -3.38%
Feb 28 101.22 99.79
103.83
99.79
144.58K 0.17%
 
Feb 25 101.05 103.16
103.42
99.76
192.35K -2.4%
Feb 24 103.53 92.87
104.18
88.50
209.74K 8.99%
Feb 23 94.99 99.00
100.65
94.83
317.17K -3.48%
Feb 22 98.41 101.08
101.75
98.25
295.48K -4.05%
Feb 18 102.56 109.25
109.25
99.01
459.17K -8.6%
Feb 17 112.21 120.67
121.89
110.93
170.01K -8.43%
Feb 16 122.54 122.31
124.72
120.29
113.89K -0.92%
Feb 15 123.68 121.38
124.45
120.45
99.68K 2.91%
Feb 14 120.18 121.60
123.10
119.37
104.17K -0.31%
Feb 11 120.55 120.55
124.56
119.00
163.74K 0.96%
Feb 10 119.40 122.22
128.51
118.72
169.93K -4.59%
Feb 9 125.14 124.68
126.76
123.50
202.36K 1.44%
Feb 8 123.36 123.59
125.51
121.47
72.10K -0.55%
Feb 7 124.04 118.57
124.79
118.57
83.76K 4.30%